BCPC

Balchem Corporation NASDAQ

Basic Materials ·Chemicals - Specialty ·US · balchem.com

$162.10

Mkt Cap $5.2B

52w Low $139.17 51.3% of range 52w High $183.90

50d MA $172.54 200d MA $161.25

P/E (TTM) 33.6x

EV/EBITDA 20.1x

P/B 4.2x

Debt/Equity 0.1x

ROE 3.1%

P/FCF 28.9x

RSI (14) —

ATR (14) —

Beta 0.95

50d MA $172.54

200d MA $161.25

Avg Volume 197.1K

About

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutr…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 20, 2026	BMO	1.29	1.31	+1.6%	175.00	-0.3%	-2.1%	+0.4%	+2.0%	+2.6%	+3.0%	—
Oct 21, 2025	BMO	1.36	1.35	-0.7%	150.77	+0.3%	+4.1%	+4.1%	+4.0%	+3.9%	+2.5%	—
Jul 31, 2025	BMO	1.25	1.27	+1.6%	152.09	-1.4%	+0.2%	+0.1%	+2.2%	+2.8%	+5.2%	—
Apr 24, 2025	BMO	1.25	1.22	-2.4%	158.31	-1.3%	-2.6%	-2.9%	-1.4%	-1.5%	-1.1%	—
Feb 21, 2025	BMO	1.11	1.03	-7.2%	161.34	+3.5%	+1.5%	+2.6%	+7.6%	+7.0%	+6.6%	—
Oct 25, 2024	BMO	1.11	1.13	+1.8%	166.16	+9.6%	+3.2%	+2.8%	+1.9%	+1.6%	+0.7%	—
Jul 26, 2024	BMO	1.03	1.09	+5.8%	174.81	+2.1%	+3.4%	+3.9%	+1.9%	+1.5%	+0.7%	—
May 3, 2024	BMO	0.98	1.03	+5.1%	146.28	+0.5%	+2.8%	+4.8%	+6.3%	+4.8%	+6.0%	—
Feb 16, 2024	BMO	0.93	0.95	+2.2%	146.39	+1.1%	+1.9%	+7.4%	+5.0%	+6.1%	+7.2%	—
Oct 27, 2023	BMO	0.97	1.04	+7.2%	121.68	-5.5%	-5.4%	-5.0%	-4.5%	-4.1%	-2.3%	—
Jul 28, 2023	BMO	0.84	1.06	+26.2%	128.54	+0.8%	+1.8%	+4.8%	+3.6%	+5.0%	+4.2%	—
Apr 28, 2023	BMO	0.78	0.70	-10.3%	126.29	+1.8%	+4.0%	+3.7%	+3.3%	+3.5%	+2.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$175.68	$175.00	-0.4%	+1.6%	+2.2%	+2.6%	+3.3%	+4.3%
Oct 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$156.89	$157.83	+0.6%	+0.1%	-0.1%	-0.1%	-1.5%	-1.1%
Aug 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$152.17	$153.04	+0.6%	+2.1%	+2.8%	+5.1%	+4.8%	+4.7%
Apr 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$153.64	$153.93	+0.2%	+1.6%	+1.5%	+1.9%	+2.1%	+5.4%
Feb 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$163.73	$163.48	-0.2%	+1.1%	+6.0%	+5.5%	+5.1%	+6.3%
Nov 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$171.46	$171.50	+0.0%	+0.6%	+2.2%	+7.0%	+3.0%	+4.6%
Jul 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$178.16	$176.42	-1.0%	-0.4%	-1.2%	-3.8%	-7.8%	-7.3%
May 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$150.40	$152.00	+1.1%	+1.9%	+3.4%	+1.9%	+3.1%	+4.0%
Feb 20	HC Wainwright & Co.	Maintains	Buy → Buy	—	$149.20	$148.46	-0.5%	+5.4%	+3.0%	+4.1%	+5.1%	+4.2%
Oct 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$115.08	$114.74	-0.3%	+0.4%	+1.0%	+1.4%	+3.3%	+5.2%
Jul 31	HC Wainwright & Co.	Maintains	Buy → Buy	—	$130.85	$131.68	+0.6%	+3.0%	+1.8%	+3.1%	+2.4%	+2.7%
Jun 5	HC Wainwright & Co.	Maintains	Buy → Buy	—	$132.82	$131.63	-0.9%	-2.8%	-0.6%	+2.0%	+1.2%	+0.5%
Feb 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$131.76	$131.62	-0.1%	-1.1%	-1.3%	+0.7%	-0.5%	+0.7%
Nov 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$137.13	$138.00	+0.6%	-3.0%	-2.6%	-2.8%	+3.3%	+2.8%
Aug 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$138.00	$138.40	+0.3%	+0.7%	-1.2%	-0.6%	+2.5%	+0.0%
May 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	$123.20	$122.87	-0.3%	-0.9%	-0.7%	+1.8%	-2.1%	-3.2%
Mar 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$134.13	$133.24	-0.7%	-2.2%	+1.4%	+1.4%	-0.5%	-0.7%
Feb 22	Sidoti & Co.	Upgrade	Neutral → Buy	—	$138.01	$139.38	+1.0%	+1.5%	-0.3%	+0.5%	+2.2%	+0.2%
Jan 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$158.94	$158.59	-0.2%	-1.3%	-1.1%	-0.4%	-1.3%	-2.2%
Nov 29	Sidoti & Co.	Downgrade	Buy → Neutral	—	$165.28	$163.53	-1.1%	-1.8%	-4.4%	-4.9%	-3.0%	-4.4%
Aug 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	$134.89	$134.89	+0.0%	-1.3%	-2.1%	-2.9%	-1.7%	-0.8%
Aug 2	Stephens & Co.	Downgrade	Overweight → Equal Weight	—	$134.89	$134.89	+0.0%	-1.3%	-2.1%	-2.9%	-1.7%	-0.8%
Feb 22	HC Wainwright & Co.	Maintains	Buy → Buy	—	$114.55	$120.36	+5.1%	+6.1%	+5.4%	+7.1%	+4.8%	+4.2%
Feb 22	Stephens & Co.	Upgrade	Equal Weight → Overweight	—	$114.55	$120.36	+5.1%	+6.1%	+5.4%	+7.1%	+4.8%	+4.2%
Aug 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$101.73	$102.74	+1.0%	-1.6%	+0.0%	+0.2%	+1.7%	+1.1%
Jul 10	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$91.61	$91.69	+0.1%	+3.0%	+2.4%	+4.5%	+7.5%	+7.8%
May 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$87.24	$87.09	-0.2%	-1.8%	-1.4%	-2.6%	-2.7%	-1.4%
Feb 24	HC Wainwright & Co.	Maintains	Buy → Buy	—	$103.18	$99.68	-3.4%	-3.1%	-5.8%	-5.9%	-8.2%	-8.5%
May 6	Pivotal Research	Downgrade	Buy → Hold	—	$102.75	$100.00	-2.7%	-2.2%	-3.4%	-3.4%	-2.8%	-2.4%
Oct 16	Sidoti & Co.	Upgrade	Neutral → Buy	—	$96.31	$98.93	+2.7%	+2.8%	+4.7%	+4.2%	+4.1%	+3.7%
Sep 25	H.C. Wainwright	Maintains	Buy → Buy	—	$114.97	$116.50	+1.3%	+0.7%	-0.9%	-1.5%	-2.5%	-3.6%
May 7	Vertical Group	Downgrade	Buy → Hold	—	$92.83	$94.05	+1.3%	+1.1%	+2.4%	+1.9%	+1.2%	+0.9%
May 7	Vertical Research	Downgrade	Buy → Hold	—	$92.83	$94.05	+1.3%	+1.1%	+2.4%	+1.9%	+1.2%	+0.9%
May 7	Pivotal Research	Upgrade	Sell → Hold	—	$92.83	$94.05	+1.3%	+1.1%	+2.4%	+1.9%	+1.2%	+0.9%
Nov 4	Pivotal Research	Downgrade	Hold → Sell	—	$71.78	$71.23	-0.8%	-1.9%	-4.5%	-4.5%	+0.8%	+4.3%
Mar 8	Sidoti & Co.	Downgrade	Buy → Neutral	—	$64.98	$63.00	-3.0%	-9.3%	-7.8%	-9.2%	-7.0%	-9.5%
Feb 2	Sidoti & Co.	Upgrade	Neutral → Buy	—	$56.58	$58.23	+2.9%	+11.5%	+14.9%	+10.4%	+8.6%	+9.5%
Jun 24	Pivotal Research	Downgrade	Buy → Hold	—	$63.81	$63.62	-0.3%	-8.4%	-9.2%	-8.2%	-11.9%	-12.7%
May 6	PiperJaffray	Maintains	Overweight → Overweight	—	$61.16	$60.72	-0.7%	-5.2%	-4.5%	-9.4%	-8.4%	-7.2%
May 6	Piper Sandler	Maintains	Overweight → Overweight	—	$61.16	$60.72	-0.7%	-5.2%	-4.5%	-9.4%	-8.4%	-7.2%
May 30	PiperJaffray	Maintains	Overweight → Overweight	—	$46.84	$47.04	+0.4%	+0.6%	+2.5%	+3.6%	+2.7%	+0.9%
Mar 7	Sidoti & Co.	Downgrade	Buy → Neutral	—	$42.96	$42.85	-0.3%	-2.4%	-2.4%	-3.1%	-3.2%	-2.3%
Feb 22	DA Davidson	Upgrade	Underperform → Buy	—	$38.01	$38.09	+0.2%	+3.7%	+2.1%	+4.6%	+4.9%	+6.1%
Aug 1	DA Davidson	Maintains	Underperform → Underperform	—	$33.33	$33.40	+0.2%	-1.8%	-0.8%	+2.7%	+5.1%	+5.6%

Recent Filings

8-K

Balchem Corporation -- 8-K Filing

Balchem Corporation reported strong Q4 2025 results with $263.6 million in sales and $39.2 million in net earnings, demonstrating solid profitability and cash generation for the specialty nutrition company.

Feb 20

8-K · 5.02 !!! Very High

Balchem Corporation -- 8-K 5.02: Executive Change

Balchem Corporation appointed Erin L. Gilson as Vice President effective April 1, 2026, representing internal leadership development with minimal immediate investor impact.

Feb 19

Data updated apr 24, 2026 8:56pm · Source: massive.com